Beckman Coulter Life Sciences leading the way to help labs comply with confidence for upcoming annex 1 regulation deadline

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, continues its relentless commitment to providing laboratories of all sizes with individualized and tailored support to meet the evolving list of regional and global compliance requirements.

TG Therapeutics to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to support the development and commercialization of azer-cel, its allogeneic CD19 CAR T cell therapy program, for the treatment of AD

​​​​​​​MaxCyte, Inc., a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics, today announced they are

Read More »